欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4905/001
药品名称Cytotect CP Biotest
活性成分
    • cytomegaly-immunoglobulin human 100.0 U/ml
剂型Solution for infusion
上市许可持有人Biotest Pharma GmbH Landsteinerstraße 5 D-63303 Dreieich Germany
参考成员国 - 产品名称Germany (DE)
Cytotect CP Biotest
互认成员国 - 产品名称
    • Ireland (IE)
    • Romania (RO)
    • Czechia (CZ)
      CYTOTECT CP BIOTEST
    • United Kingdom (Northern Ireland) (XI)
    • Lithuania (LT)
    • Slovakia (SK)
    • Belgium (BE)
      Megalotect 100 E/ml oplossing voor infusie
    • Austria (AT)
      Cytotect CP Biotest 100 E/ml Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
      Megalotect CP
    • Hungary (HU)
      CYTOTECT CP BIOTEST 100 E/ml oldatos infúzió
    • Slovenia (SI)
    • Croatia (HR)
      Cytotect CP Biotest 100 U/ml otopina za infuziju
    • Netherlands (NL)
许可日期2018/08/01
最近更新日期2024/04/05
药物ATC编码
    • J06BB09 cytomegalovirus immunoglobulin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Biological: Blood Product
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase